ArticleJAMA network open2023
Prevalence of Positive COVID-19 Test Results Collected by Digital Self-report in the US and Germany.
Article in JAMA network open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Feasibility of wearable sensor signals and self-reported symptoms to prompt at-home testing for acute respiratory viruses in the USA (DETECT-AHEAD): a decentralised, randomised controlled trial.The Lancet. Digital health · 2024Trial
- Sensor wide association studies in digital medicine.NPJ digital medicine · 2026Review
- Wearable data reveals distinct characteristics of individuals with persistent symptoms after a SARS-CoV-2 infection.NPJ digital medicine · 2025Article
- Optimizing COVID-19 testing resources use with wearable sensors.PLOS digital health · 2024Article
- Objectively measured peri-vaccination sleep does not predict COVID-19 breakthrough infection.Scientific reports · 2024Article
- Citizen data sovereignty is key to wearables and wellness data reuse for the common good.NPJ digital medicine · 2024Article
- COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: A repeated cross-sectional study.PLOS global public health · 2024Article
- Estimating the share of SARS-CoV-2-immunologically naïve individuals in Germany up to June 2022.Epidemiology and infection · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.